Sweden · Delayed Price · Currency is SEK Humana AB Statistics
Total Valuation
Humana AB has a market cap or net worth of SEK 2.06 billion. The enterprise value is 6.23 billion.
| Market Cap | 2.06B |
| Enterprise Value | 6.23B |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | May 8, 2026 |
Share Statistics
Humana AB has 48.34 million shares outstanding. The number of shares has decreased by -0.47% in one year.
| Current Share Class | 48.34M |
| Shares Outstanding | 48.34M |
| Shares Change (YoY) | -0.47% |
| Shares Change (QoQ) | -1.35% |
| Owned by Insiders (%) | 2.41% |
| Owned by Institutions (%) | 23.46% |
| Float | 27.41M |
Valuation Ratios
The trailing PE ratio is 9.01 and the forward PE ratio is 7.38.
| PE Ratio | 9.01 |
| Forward PE | 7.38 |
| PS Ratio | 0.20 |
| PB Ratio | 0.63 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.09 |
| P/OCF Ratio | 2.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.69, with an EV/FCF ratio of 9.36.
| EV / Earnings | 26.42 |
| EV / Sales | 0.62 |
| EV / EBITDA | 5.69 |
| EV / EBIT | 12.30 |
| EV / FCF | 9.36 |
Financial Position
The company has a current ratio of 0.67, with a Debt / Equity ratio of 1.35.
| Current Ratio | 0.67 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | 4.02 |
| Debt / FCF | 6.61 |
| Interest Coverage | 2.20 |
Financial Efficiency
Return on equity (ROE) is 7.24% and return on invested capital (ROIC) is 5.62%.
| Return on Equity (ROE) | 7.24% |
| Return on Assets (ROA) | 3.17% |
| Return on Invested Capital (ROIC) | 5.62% |
| Return on Capital Employed (ROCE) | 7.08% |
| Weighted Average Cost of Capital (WACC) | 4.56% |
| Revenue Per Employee | 605,757 |
| Profits Per Employee | 14,181 |
| Employee Count | 22,000 |
| Asset Turnover | 1.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana AB has paid 52.00 million in taxes.
| Income Tax | 52.00M |
| Effective Tax Rate | 17.99% |
Stock Price Statistics
The stock price has increased by +17.44% in the last 52 weeks. The beta is 0.16, so Humana AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +17.44% |
| 50-Day Moving Average | 48.64 |
| 200-Day Moving Average | 42.20 |
| Relative Strength Index (RSI) | 36.70 |
| Average Volume (20 Days) | 145,006 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Humana AB had revenue of SEK 10.08 billion and earned 236.00 million in profits. Earnings per share was 4.73.
| Revenue | 10.08B |
| Gross Profit | 2.20B |
| Operating Income | 507.00M |
| Pretax Income | 289.00M |
| Net Income | 236.00M |
| EBITDA | 606.00M |
| EBIT | 507.00M |
| Earnings Per Share (EPS) | 4.73 |
Balance Sheet
The company has 366.00 million in cash and 4.40 billion in debt, with a net cash position of -4.04 billion or -83.49 per share.
| Cash & Cash Equivalents | 366.00M |
| Total Debt | 4.40B |
| Net Cash | -4.04B |
| Net Cash Per Share | -83.49 |
| Equity (Book Value) | 3.26B |
| Book Value Per Share | 64.47 |
| Working Capital | -748.00M |
Cash Flow
In the last 12 months, operating cash flow was 770.00 million and capital expenditures -104.00 million, giving a free cash flow of 666.00 million.
| Operating Cash Flow | 770.00M |
| Capital Expenditures | -104.00M |
| Free Cash Flow | 666.00M |
| FCF Per Share | 13.78 |
Margins
Gross margin is 21.80%, with operating and profit margins of 5.03% and 2.34%.
| Gross Margin | 21.80% |
| Operating Margin | 5.03% |
| Pretax Margin | 2.87% |
| Profit Margin | 2.34% |
| EBITDA Margin | 6.01% |
| EBIT Margin | 5.03% |
| FCF Margin | 6.61% |
Dividends & Yields
This stock pays an annual dividend of 1.35, which amounts to a dividend yield of 3.17%.
| Dividend Per Share | 1.35 |
| Dividend Yield | 3.17% |
| Dividend Growth (YoY) | 35.00% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 21.19% |
| Buyback Yield | 0.47% |
| Shareholder Yield | 3.58% |
| Earnings Yield | 11.46% |
| FCF Yield | 32.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Humana AB has an Altman Z-Score of 1.65 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 6 |